National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management

INMI COVID-19 Treatment Group (ICOTREG)

Research output: Contribution to journalArticlepeer-review

Abstract

On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data. n-

Original languageEnglish
Pages (from-to)3-9
Number of pages7
JournalInfectious Disease Reports
Volume12
Issue number1
DOIs
Publication statusPublished - Feb 20 2020

Keywords

  • COVID-19
  • SARS-CoV-2
  • Treatment

ASJC Scopus subject areas

  • Infectious Diseases

Fingerprint

Dive into the research topics of 'National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management'. Together they form a unique fingerprint.

Cite this